KOR
ENG
Contact
Home
About
Solutions
R&D
IR
Newsroom
Request a Demo
Histological proven AI performance in the UKLS CT lung cancer screening study: Potential for workload reduction
Solution
Deciphering the intratumoral histologic heterogeneity of lung adenocarcinoma using radiomics
Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC
Prognostic Implications of the Volume Doubling Time of the Solid Component in Lung Adenocarcinomas Manifesting as Part-Solid Lesions on Chest CT
Feasibility of AI as First Reader in the 4-IN-THE-LUNG-RUN Lung Cancer Screening Trial: Impact on Negative-Misclassifications and Clinical Referral Rate
Comparative Outcomes of Surgery and SBRT for Stage I Lung Cancer in Koreans: A Propensity Matched Multidisciplinary Cohort Study
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial
High Recruitment Rate and Performance of a National Lung Cancer Screening Network Implementing Web-Based Instruments
문의하기
일반 문의
T+82. 2. 571. 7321
F+82. 2. 571. 7324
국내 사업부
T+82. 70. 7711. 6061
Esales@corelinesoft.com
해외 사업부
T+82. 70. 7711. 6064
Eobd@corelinesoft.com
기술지원팀
T+82. 70. 7711. 6063
Esupport@corelinesoft.com
IR 관련 문의
T+82. 2. 336. 7321
Eir@corelinesoft.com
유럽 법인
T+49. 69. 5800. 11870
Einfo@corelinesoft.eu
Gaugrafenstraße 34 60489 Frankfurt am Main, Germany
북미 법인
T+1. 470. 881. 2747
Eusa@corelinesoft.com
530 Highland Station Dr., STE 2002, Suwanee, GA 30024